C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Buys New Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 32,708 shares of the company’s stock, valued at approximately $471,000.

Other large investors have also bought and sold shares of the company. Brown Brothers Harriman & Co. bought a new position in shares of BlackRock Health Sciences Term Trust in the third quarter worth approximately $32,000. K2 Principal Fund L.P. purchased a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter valued at $158,000. Jane Street Group LLC bought a new stake in BlackRock Health Sciences Term Trust in the 3rd quarter worth $357,000. Dakota Wealth Management increased its position in shares of BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after acquiring an additional 4,267 shares during the period. Finally, Kingswood Wealth Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at about $420,000.

BlackRock Health Sciences Term Trust Trading Up 0.1 %

BlackRock Health Sciences Term Trust stock opened at $16.05 on Friday. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.75. The firm has a 50-day moving average of $15.55 and a 200-day moving average of $15.67.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be given a $0.1773 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $2.13 dividend on an annualized basis and a dividend yield of 13.26%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.